MTM1 mutations in X‐linked myotubular myopathy

…, SM Tanner, W Kress, V Schneider… - Human …, 2000 - Wiley Online Library
X‐linked myotubular myopathy (XLMTM; MIM# 310400) is a severe congenital muscle
disorder caused by mutations in the MTM1 gene. This gene encodes a dual‐specificity …

[PDF][PDF] Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis

E Patsenker, Y Popov, F Stickel, V Schneider… - …, 2009 - Wiley Online Library
The vitronectin receptor integrin αvβ3 promotes angiogenesis by mediating migration and
proliferation of endothelial cells, but also drives fibrogenic activation of hepatic stellate cells (…

Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis

M Neef, M Ledermann, H Saegesser, V Schneider… - Journal of …, 2006 - Elsevier
BACKGROUND/AIMS: Mammalian target of rapamycin (mTOR) signalling is central in the
activation of hepatic stellate cells (HSCs), the key source of extracellular matrix (ECM) in …

Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe [see comments]

…, A von Rohr, B Borisch, L Theilkas, V Schneider… - 1994 - ashpublications.org
About 80% to 90% of females are informative for X- inactivation/methylation analysis with
the probe M27 beta, which would therefore seem attractive in assessing clonality in …

Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis

E Patsenker, V Schneider, M Ledermann… - Journal of …, 2011 - Elsevier
BACKGROUND & AIMS: Recurrence of chronic hepatitis C and progressive fibrosis in liver
transplants is frequent and impairs both graft and patient survival. Whether or not the choice …

[HTML][HTML] Cannabinoid receptor type I modulates alcohol-induced liver fibrosis

…, G Millonig, A Agaimy, T Wissniowski, V Schneider… - Molecular …, 2011 - Springer
The cannabinoid system (CS) is implicated in the regulation of hepatic fibrosis, steatosis
and inflammation, with cannabinoid receptors 1 and 2 (CB1 and CB2) being involved in …

Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term

M Neef, M Ledermann, H Saegesser, V Schneider… - Journal of …, 2006 - Elsevier
BACKGROUND/AIMS: Transactivated hepatic stellate cells (HSCs) represent the key
source of extra cellular matrix (ECM) in fibrotic liver. Imatinib, a potent inhibitor of the PDGF …

Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms

…, M Neef, M Unternährer, V Schneider… - … of Pharmacology and …, 2005 - ASPET
Rapamycin is an immunosuppressant with antiproliferative properties. We investigated
whether rapamycin treatment of bile duct-ligated (BDL) rats is capable of inhibiting liver fibrosis …

Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy

E Matovu, F Geiser, V Schneider, P Mäser… - Molecular and …, 2001 - Elsevier
We have analyzed the TbAT1 gene, which codes for the P2 adenosine transporter, from
Trypanosoma brucei field isolates to investigate a possible link between the presence of …

Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic …

S Liechti-Gallati, V Schneider, D Neeser… - European Journal of …, 1999 - nature.com
The large size of many disease genes and the multiplicity of mutations complicate the design
of an adequate assay for the identification of disease-causing variants. One of the most …